Ensuring psychedelic treatments and research do not leave anyone behind.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology January 1, 2024 DOI: 10.1038/s41386-023-01710-4 via PubMed
Summary
AI-generated from the abstractPsychedelics show promise for treating severe mental illness, but health equity and justice concerns must be addressed in US clinical care and research. Strategies are needed to reduce existing disparities and prevent future disparities among minoritized and marginalized populations.
Study at a glance
| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Topics | Psychedelic-assisted therapy |
| Keywords | Mental health equity Healthcare access Marginalized communities Clinical trials diversity |
| Citations | 6 |
| Key finding | Health equity and justice must be addressed in psychedelic care delivery and research to reduce and preempt disparities among minoritized and marginalized populations. |
Abstract
Psychedelics are a promising approach to caring for persons living with severe mental illness. However, as with all clinical treatments and research in the US, health equity concerns must be considered and addressed. Ensuring health equity and health justice in psychedelic care delivery and research will require strategies to not only reduce disparities and preempt future disparities among minoritized and marginalized populations.